(Q46766425)

25 December 2017

title

Lanthanum carbonate effectively controls serum phosphate without affecting serum calcium levels in patients undergoing hemodialysis (English)

1 reference

25 December 2017

1 reference

1 reference

Takashi Shigematsu

1

1 reference

25 December 2017

Lanthanum Carbonate Research Group

series ordinal

2

1 reference

25 December 2017

publication date

1 February 2008

1 reference

25 December 2017

Therapeutic Apheresis and Dialysis

published in

1 reference

25 December 2017

volume

12

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

55-61

1 reference

25 December 2017

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00541.X

Increased resistin blood levels are not associated with insulin resistance in patients with renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00541.X

Determinants of progressive vascular calcification in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00541.X

Combination therapy with sevelamer hydrochloride and calcium carbonate in Japanese patients with long-term hemodialysis: alternative approach for optimal mineral management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00541.X

Lanthanum carbonate for the treatment of hyperphosphataemia in renal failure and dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00541.X

Efficacy of combined sevelamer and calcium carbonate therapy for hyperphosphatemia in Japanese hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00541.X

Prospective randomized multicenter trial of sevelamer hydrochloride and calcium carbonate for the treatment of hyperphosphatemia in hemodialysis patients in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00541.X

Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00541.X

10.1111/J.1744-9987.2007.00541.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017